Betagen Topical Spray for Dogs, 240 ml, Rx

DOSAGE AND ADMINISTRATION:
Prior to treatment, remove excessive hair and clean the lesion and adjacent area. Hold bottle upright 3 to 6 inches from the lesion and depress the sprayer head twice. Administer 2 to 4 times daily for 7 days.

Each depression of the sprayer head delivers 0.7 mL of Gentamicin Sulfate with Betamethasone Valerate Topical Spray.

Active Ingredients (per ml):
Gentamicin Sulfate - 0.57 mg
Betamethasone Valerate - 0.284 mg
Isopropyl Alcohol - 163 mg
Propylene Glycol
Methylparaben (a preservative)
Propylparaben (a preservative)
Purified Water
* Hydrochloric acid may be added to adjust pH.

CAUTION:
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
For Topical Use in Dogs Only

WARNING:
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis.

Additionally, corticosteroids administered to dogs, rabbits and rodents during pregnancy have produced cleft palate. Other congenital anomalies including deformed forelegs, phocomelia, and anasarca have been reported in offspring of dogs which received corticosteroids during pregnancy.

CONTRAINDICATIONS:
If hypersensitivity to any of the components occurs, treatment with this product should be discontinued and appropriate therapy instituted.

PRECAUTIONS:
Antibiotic susceptibility of the pathogenic organism(s) should be determined prior to the use of this preparation. Use of topical antibiotics may permit overgrowth of non-susceptible bacteria, fungi, or yeasts. If this occurs, treatment should be instituted with other appropriate agents as indicated. Administration of recommended dose beyond 7 days may result in delayed wound healing. Animals treated longer than 7 days should be monitored closely.

Avoid ingestion. Oral or parenteral use of corticosteroids, depending on dose, duration, and specific steroid may result in inhibition of endogenous steroid production following drug withdrawal. In patients presently receiving or recently withdrawn from systemic corticosteroid treatments, therapy with a rapidly acting corticosteroid should be considered in especially stressful situations.

If ingestion should occur, patients should be closely observed for the usual signs of adrenocorticoid overdosage which include sodium retention, potassium loss, fluid retention, weight gains, polydipsia, and/or polyuria. Prolonged use or overdosage may produce adverse immunosuppressive effects.

Prescription

This item requires a valid prescription from a licensed veterinarian.